Luís Meza

Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer

Frankie A. Holmes, Joyce O’Shaughnessy, S. Vukelja et al. · Journal of Clinical Oncology · 2002 · 517 citations

Medicine, Oncology, Pharmacology +17

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot et al. · Nature Medicine · 2022 · 473 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer

Frankie A. Holmes, Stephen E. Jones, Joyce O’Shaughnessy et al. · Annals of Oncology · 2002 · 292 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23

Nelson B. Freimer, Victor I. Reus, Michael Escamilla et al. · Nature Genetics · 1996 · 256 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees

L. Alison McInnes, Michael Escamilla, Susan K. Service et al. · Proceedings of the National Academy of Sciences · 1996 · 170 citations · Full text

Life Sciences, Genetics, Psychiatry +17